A misdiagnosed emergency nurse’s severe headaches reveal key signs and symptoms of a cluster headache and the importance of ...

Daylight saving time is famously brutal on the body, disrupting sleep and leaving much of the nation groggy for days ...

Compared with placebo, eptinezumab failed to significantly reduce the number of episodic cluster headache (ECH) attacks but showed higher responder rates and improved quality-of-life measures. "Among ...

Preventive treatment with the calcitonin gene-related peptide (CGRP) receptor monoclonal antibody erenumab for 6 weeks was not associated with significant reductions in weekly headache attacks, pain ...

Eli Lilly secured federal approval for Emgality, the first migraine treatment approved in the U.S. for decreasing the frequency of episodic cluster headache attacks, the FDA announced June 4. 1.

Please provide your email address to receive an email when new articles are posted on . Approximately one in 1,000 people have cluster headaches. Cluster headaches are nicknamed “suicide headaches” ...

Cluster headache disorders constitute some of the most excruciating primary headache syndromes encountered in clinical practice. These conditions are typified by recurrent, strictly unilateral attacks ...

Prednisone is a corticosteroid that’s commonly used across a wide range of medical specialties for its anti-inflammatory properties. In neurology, it has emerged as a therapeutic option for the acute ...

The FDA approved dihydroergotamine (DHE) mesylate injection (Brekiya) to treat acute migraine (with or without aura) and cluster headaches in adults, Amneal Pharmaceuticals announced Thursday. The ...

We’ve all been there—trying to power through the day while an unwelcome drummer performs a solo inside our skull. You reach for the pain relievers and hope it passes quickly. But that throbbing in ...